Alison Kyle Handel

Alison Kyle Handel, MS, is a seasoned business leader in the oncology and hematology sectors with extensive experience in commercial sales and strategic development. Currently serving as Vice President of Commercial-Oncology at Quest Diagnostics since April 2023, Alison focuses on transforming the oncology and pathology commercial organization. Prior to this role, Alison was Vice President of Commercial Sales for Cancer Screening Early Detection at Guardant Health, leading a team to achieve a remarkable 300% exceeding of launch sales goals. With previous significant leadership positions at Bristol Myers Squibb, Celgene, Astellas Pharma, Roche, and Johnson & Johnson, Alison has demonstrated a consistent ability to develop and lead high-performing teams, execute strategic initiatives, and drive growth across various therapeutic areas. Alison holds a Bachelor's Degree in Business Marketing and Management from Indiana University and a Master's Degree from the Indiana University Richard M. Fairbanks School of Public Health.